A detailed history of Jnba Financial Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Jnba Financial Advisors holds 11,482 shares of PFE stock, worth $340,556. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,482
Previous 13,020 11.81%
Holding current value
$340,556
Previous $361,000 11.08%
% of portfolio
0.03%
Previous 0.04%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$25.26 - $29.6 $38,849 - $45,524
-1,538 Reduced 11.81%
11,482 $321,000
Q1 2024

Apr 26, 2024

SELL
$25.89 - $29.73 $6,860 - $7,878
-265 Reduced 1.99%
13,020 $361,000
Q4 2023

Feb 07, 2024

SELL
$26.13 - $33.94 $1,985 - $2,579
-76 Reduced 0.57%
13,285 $382,000
Q3 2023

Nov 02, 2023

SELL
$32.09 - $37.51 $5,134 - $6,001
-160 Reduced 1.18%
13,361 $443,000
Q2 2023

Aug 03, 2023

BUY
$36.12 - $41.79 $16,001 - $18,512
443 Added 3.39%
13,521 $495,000
Q1 2023

May 01, 2023

BUY
$39.39 - $51.28 $590 - $769
15 Added 0.11%
13,078 $533,000
Q4 2022

Feb 06, 2023

SELL
$41.75 - $54.5 $137,107 - $178,978
-3,284 Reduced 20.09%
13,063 $669,000
Q3 2022

Nov 07, 2022

BUY
$43.76 - $53.42 $46,910 - $57,266
1,072 Added 7.02%
16,347 $715,000
Q2 2022

Jul 22, 2022

SELL
$46.53 - $55.17 $8,840 - $10,482
-190 Reduced 1.23%
15,275 $801,000
Q1 2022

Apr 29, 2022

SELL
$45.75 - $56.69 $69,814 - $86,508
-1,526 Reduced 8.98%
15,465 $801,000
Q4 2021

Feb 03, 2022

BUY
$41.32 - $61.25 $12,561 - $18,620
304 Added 1.82%
16,991 $1 Million
Q2 2021

Aug 04, 2021

BUY
$35.91 - $40.68 $44,025 - $49,873
1,226 Added 7.93%
16,687 $653,000
Q1 2021

May 03, 2021

BUY
$33.49 - $37.77 $1,908 - $2,152
57 Added 0.37%
15,461 $560,000
Q4 2020

Jan 25, 2021

BUY
$33.47 - $42.56 $13,990 - $17,790
418 Added 2.79%
15,404 $567,000
Q3 2020

Nov 05, 2020

SELL
$31.75 - $37.25 $2,571 - $3,017
-81 Reduced 0.54%
14,986 $550,000
Q2 2020

Jul 24, 2020

SELL
$30.12 - $36.54 $3,975 - $4,823
-132 Reduced 0.87%
15,067 $493,000
Q1 2020

May 01, 2020

BUY
$27.03 - $38.62 $5,108 - $7,299
189 Added 1.26%
15,199 $496,000
Q4 2019

Feb 10, 2020

BUY
$32.92 - $37.36 $24,262 - $27,534
737 Added 5.16%
15,010 $588,000
Q3 2019

Nov 01, 2019

SELL
$32.49 - $42.13 $10,559 - $13,692
-325 Reduced 2.23%
14,273 $513,000
Q2 2019

Jul 26, 2019

BUY
$36.98 - $41.52 $19,377 - $21,756
524 Added 3.72%
14,598 $632,000
Q1 2019

May 01, 2019

BUY
$37.5 - $41.2 $200,287 - $220,049
5,341 Added 61.16%
14,074 $598,000
Q4 2018

Feb 07, 2019

SELL
$38.47 - $43.86 $4.11 Million - $4.68 Million
-106,724 Reduced 92.44%
8,733 $381,000
Q3 2018

Nov 01, 2018

BUY
$34.47 - $41.81 $3.68 Million - $4.46 Million
106,724 Added 1222.08%
115,457 $5.09 Million
Q2 2018

Jul 17, 2018

BUY
$32.98 - $35.16 $73,743 - $78,617
2,236 Added 34.42%
8,733 $317,000
Q2 2017

Aug 14, 2017

BUY
N/A
6,497
6,497 $218,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Jnba Financial Advisors Portfolio

Follow Jnba Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.